4.7 Review

The gut microbiota and Type 1 Diabetes

期刊

CLINICAL IMMUNOLOGY
卷 159, 期 2, 页码 143-153

出版社

ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.clim.2015.05.013

关键词

Type 1 Diabetes; Gut microbiota; Gut permeability; Treg; Th17 cells

资金

  1. Deutsche Forschungsgemeinschaft [GU 1122/3-1]
  2. EFSD/Novo Nordisk Programme
  3. MRC [MR/K021141/1]
  4. [RC1 DK092882]
  5. [DK088181]
  6. [P30-DK045735]
  7. Medical Research Council [MR/K021141/1] Funding Source: researchfish
  8. NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, R01DK100500, R01DK092882, R01DK088181] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Type 1 Diabetes (T1D) is a multifactorial, immune-mediated disease, which is characterized by the progressive destruction of autologous insulin-producing beta cells in the pancreas. The risk of developing T1D is determined by genetic, epigenetic and environmental factors. In the past few decades there has been a continuous rise in the incidence of T1D, which cannot be explained by genetic factors alone. Changes in our lifestyle that include diet, hygiene, and antibiotic usage have already been suggested to be causal factors for this rising T1D incidence. Only recently have microbiota, which are affected by all these factors, been recognized as key environmental factors affecting T1D development. In this review we will summarize current knowledge on the impact of gut microbiota on T1D development and give an outlook on the potential to design new microbiota-based therapies in the prevention and treatment of T1D. (C) 2015 Published by Elsevier Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据